| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 10 | 0 | 0 | 10 |
| Luciferase | 6 | 0 | 0 | 6 |
| RAR-related orphan receptor gamma | 11 | 0 | 0 | 11 |
| retinoid X nuclear receptor alpha | 6 | 0 | 0 | 6 |
| G | 9 | 0 | 0 | 9 |
| peroxisome proliferator activated receptor gamma | 7 | 0 | 0 | 7 |
| euchromatic histone-lysine N-methyltransferase 2 | 15 | 0 | 0 | 15 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| chromobox protein homolog 1 | 8 | 0 | 0 | 8 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
| geminin | 12 | 0 | 0 | 12 |
| muscleblind-like protein 1 isoform 1 | 4 | 0 | 0 | 4 |
| Interferon beta | 10 | 0 | 0 | 10 |
| HLA class I histocompatibility antigen, B alpha chain | 9 | 0 | 0 | 9 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| Inositol hexakisphosphate kinase 1 | 9 | 0 | 0 | 9 |
| cytochrome P450 2C9, partial | 9 | 0 | 0 | 9 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| Chain A, HADH2 protein | 5 | 0 | 0 | 5 |
| Chain B, HADH2 protein | 5 | 0 | 0 | 5 |
| Chain A, 2-oxoglutarate Oxygenase | 6 | 0 | 0 | 6 |
| GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
| ras protein, partial | 0 | 0 | 1 | 1 |
| interleukin 8 | 2 | 0 | 0 | 2 |
| thioredoxin reductase | 7 | 0 | 0 | 7 |
| GLS protein | 7 | 0 | 0 | 7 |
| AR protein | 16 | 0 | 0 | 16 |
| aldehyde dehydrogenase 1 family, member A1 | 10 | 0 | 0 | 10 |
| thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
| hypothetical protein, conserved | 2 | 0 | 0 | 2 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 13 | 0 | 0 | 13 |
| EWS/FLI fusion protein | 9 | 0 | 0 | 9 |
| glucocorticoid receptor [Homo sapiens] | 11 | 0 | 0 | 11 |
| retinoic acid nuclear receptor alpha variant 1 | 11 | 0 | 0 | 11 |
| estrogen-related nuclear receptor alpha | 10 | 0 | 0 | 10 |
| estrogen nuclear receptor alpha | 18 | 0 | 0 | 18 |
| cytochrome P450 2D6 | 9 | 0 | 0 | 9 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| peroxisome proliferator-activated receptor delta | 6 | 0 | 0 | 6 |
| Rac1 protein | 0 | 0 | 1 | 1 |
| IDH1 | 4 | 0 | 0 | 4 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
| Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
| DNA polymerase iota isoform a (long) | 4 | 0 | 0 | 4 |
| DNA polymerase kappa isoform 1 | 4 | 0 | 0 | 4 |
| muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 7 | 0 | 7 |
| Multidrug resistance-associated protein 4 | 0 | 7 | 0 | 7 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 17 | 0 | 17 |
| Epidermal growth factor receptor | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 1 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 2 | 0 | 4 | 0 | 4 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Integrin beta-3 | 3 | 1 | 0 | 4 |
| Myeloperoxidase | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 3 | 1 | 0 | 4 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A1 | 0 | 3 | 0 | 4 |
| Adenosine receptor A2a | 0 | 3 | 1 | 6 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| Urotensin-2 receptor | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
| Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 7 | 1 | 0 | 8 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Canalicular multispecific organic anion transporter 1 | 0 | 7 | 0 | 7 |
| Sigma non-opioid intracellular receptor 1 | 0 | 5 | 1 | 6 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 1 | 2 |
| glp-1 receptor, partial | 2 | 0 | 0 | 2 |
| pregnane X receptor | 1 | 0 | 0 | 1 |
| TDP1 protein | 12 | 0 | 0 | 12 |
| GLI family zinc finger 3 | 10 | 0 | 0 | 10 |
| estrogen receptor 2 (ER beta) | 6 | 0 | 0 | 6 |
| nuclear receptor subfamily 1, group I, member 3 | 9 | 0 | 0 | 9 |
| progesterone receptor | 6 | 0 | 0 | 6 |
| farnesoid X nuclear receptor | 5 | 0 | 0 | 5 |
| pregnane X nuclear receptor | 8 | 0 | 0 | 8 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 5 | 0 | 0 | 5 |
| aryl hydrocarbon receptor | 5 | 0 | 0 | 5 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
| thyroid hormone receptor beta isoform 2 | 12 | 0 | 0 | 12 |
| steroidogenic factor 1 | 0 | 1 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 11 | 0 | 0 | 11 |
| peripheral myelin protein 22 | 5 | 0 | 0 | 5 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| relaxin receptor 2 isoform 1 | 1 | 0 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
| Rap guanine nucleotide exchange factor 3 | 4 | 0 | 0 | 4 |
| Cellular tumor antigen p53 | 10 | 0 | 0 | 10 |
| ATP-dependent translocase ABCB1 | 0 | 5 | 0 | 6 |
| 5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
| Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 0 | 1 | 1 |
| Glutamate receptor 2 | 4 | 0 | 0 | 4 |
| Adenylate cyclase type 2 | 0 | 0 | 1 | 1 |
| Adenylate cyclase type 8 | 0 | 0 | 1 | 1 |
| Adenylate cyclase type 1 | 0 | 1 | 1 | 3 |
| ATPase family AAA domain-containing protein 5 | 3 | 0 | 0 | 3 |
| Ataxin-2 | 5 | 0 | 0 | 5 |
| Relaxin receptor 1 | 0 | 0 | 1 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| USP1 protein, partial | 8 | 0 | 0 | 8 |
| Microtubule-associated protein tau | 6 | 0 | 0 | 6 |
| activating transcription factor 6 | 4 | 0 | 0 | 4 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 4 | 0 | 0 | 4 |
| heat shock protein beta-1 | 6 | 0 | 0 | 6 |
| importin subunit beta-1 isoform 1 | 4 | 0 | 0 | 4 |
| snurportin-1 | 4 | 0 | 0 | 4 |
| GTP-binding nuclear protein Ran isoform 1 | 3 | 0 | 0 | 3 |
| lamin isoform A-delta10 | 9 | 0 | 0 | 9 |
| Glutathione S-transferase P | 0 | 1 | 0 | 1 |
| Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
| hypoxia-inducible factor 1 alpha subunit | 4 | 0 | 0 | 4 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 6 | 0 | 0 | 6 |
| Histone H2A.x | 5 | 0 | 0 | 5 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
| cytochrome P450 2C9 precursor | 2 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 7 | 0 | 0 | 7 |
| cytochrome P450 3A4 isoform 1 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit pi | 7 | 0 | 0 | 7 |
| NAD | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 5 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 7 | 0 | 0 | 7 |
| NAD | 0 | 1 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit delta | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 7 | 0 | 0 | 7 |
| Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 7 | 0 | 0 | 7 |
| Histamine H2 receptor | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 7 | 0 | 0 | 7 |
| ATP phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 2 | 0 | 2 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| GABA theta subunit | 7 | 0 | 0 | 7 |
| Gamma-aminobutyric acid receptor subunit epsilon | 7 | 0 | 0 | 7 |
| G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
| endonuclease IV | 3 | 0 | 0 | 3 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
| core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
| mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
| Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| acetylcholinesterase | 5 | 0 | 0 | 5 |
| RGS12 | 1 | 0 | 0 | 1 |
| 90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
| SMAD family member 2 | 2 | 0 | 0 | 2 |
| ATAD5 protein, partial | 4 | 0 | 0 | 4 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| SMAD family member 3 | 2 | 0 | 0 | 2 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| Smad3 | 4 | 0 | 0 | 4 |
| DNA polymerase III, partial | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
| regulator of G-protein signaling 4 | 6 | 0 | 0 | 6 |
| isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 2 | 0 | 0 | 2 |
| LANA | 0 | 0 | 0 | 1 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| polyprotein | 1 | 0 | 0 | 1 |
| 67.9K protein | 2 | 0 | 0 | 2 |
| bromodomain adjacent to zinc finger domain 2B | 7 | 0 | 0 | 7 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 7 | 0 | 0 | 7 |
| lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| D(1A) dopamine receptor | 4 | 0 | 0 | 4 |
| thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 2 | 0 | 0 | 3 |
| guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
| tumor susceptibility gene 101 protein | 1 | 0 | 0 | 1 |
| nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
| survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
| histone acetyltransferase KAT2A isoform 1 | 6 | 0 | 0 | 6 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| kelch-like ECH-associated protein 1 | 0 | 0 | 0 | 2 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 3 | 0 | 4 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
| Multidrug resistance-associated protein 5 | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 2 | 2 | 6 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 2 | 2 | 6 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 4 | 0 | 4 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
| Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 2 | 0 | 2 |
| Spike glycoprotein | 6 | 0 | 0 | 6 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
| Inositol monophosphatase 1 | 3 | 0 | 0 | 3 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 4 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 4 | 0 | 4 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 4 | 0 | 4 |
| TAR DNA-binding protein 43 | 5 | 0 | 0 | 5 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 3 | 0 | 3 |
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 2 | 0 | 2 |
| Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 2 | 0 | 2 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 3 | 0 | 3 |
| Exopolyphosphatase PRUNE1 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
| Equilibrative nucleoside transporter 1 | 0 | 2 | 0 | 2 |
| Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
| Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 4 | 0 | 4 |
| Delta-type opioid receptor | 0 | 5 | 1 | 6 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 5 | 2 | 7 |
| Kappa-type opioid receptor | 0 | 1 | 1 | 2 |
| Mu-type opioid receptor | 0 | 2 | 3 | 5 |
| Delta-type opioid receptor | 0 | 3 | 2 | 5 |
| Kappa-type opioid receptor | 0 | 3 | 1 | 4 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 3 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 3 | 1 | 4 |
| Adenylate cyclase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Cytochrome P450 3A4 | 0 | 3 | 0 | 3 |
| Alpha-2A adrenergic receptor | 0 | 8 | 1 | 10 |
| D(2) dopamine receptor | 0 | 5 | 0 | 5 |
| Alpha-2B adrenergic receptor | 0 | 8 | 1 | 10 |
| Alpha-2C adrenergic receptor | 0 | 6 | 1 | 8 |
| 5-hydroxytryptamine receptor 1A | 0 | 5 | 0 | 5 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 0 | 4 | 0 | 4 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 1D | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 2C | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 1B | 0 | 4 | 0 | 4 |
| D(3) dopamine receptor | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 2B | 0 | 6 | 0 | 6 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 4 | 0 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
| phosphopantetheinyl transferase | 4 | 0 | 0 | 4 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
| N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 3 | 0 | 3 |
| Cytochrome P450 1A2 | 0 | 2 | 0 | 2 |
| Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2A6 | 0 | 3 | 1 | 4 |
| Macrophage migration inhibitory factor | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 3 | 0 | 3 |
| Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 2 |
| Pantothenate synthetase | 0 | 1 | 0 | 1 |
| Isocitrate lyase | 0 | 1 | 0 | 1 |
| Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
| Chain A, Cruzipain | 1 | 0 | 0 | 1 |
| Neprilysin | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
| Thromboxane A2 receptor | 0 | 1 | 0 | 2 |
| Type-1A angiotensin II receptor | 0 | 2 | 1 | 3 |
| Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
| Type-1 angiotensin II receptor | 0 | 2 | 1 | 5 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
| Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| Platelet glycoprotein VI | 0 | 1 | 1 | 3 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 3 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
| Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
| thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| arylsulfatase A | 6 | 0 | 0 | 6 |
| pyruvate kinase | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
| estrogen receptor beta isoform 1 | 0 | 2 | 0 | 2 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
| ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
| Ornithine decarboxylase | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 3E | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit alpha | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
| Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 2 | 5 |
| Acetylcholine receptor subunit gamma | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit beta | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 2 | 5 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 2 | 5 |
| Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit beta-like 2 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 1 | 3 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 2 | 4 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit alpha-9 | 0 | 2 | 2 | 5 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
| Acetylcholine-binding protein | 0 | 1 | 1 | 2 |
| Acetylcholine receptor subunit epsilon | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 2 | 5 |
| Acetylcholine receptor subunit delta | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
| Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
| Liver carboxylesterase B-1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3D | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Soluble acetylcholine receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3C | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-10 | 0 | 2 | 2 | 5 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
| Integrin beta | 0 | 0 | 1 | 1 |
| Glycoprotein IIb | 0 | 0 | 1 | 1 |
| Transporter | 0 | 1 | 1 | 3 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 4 | 3 | 7 |
| D | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 4 | 3 | 8 |
| D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 4 | 3 | 7 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| Hsf1 protein | 0 | 0 | 1 | 1 |
| urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
| plasminogen precursor | 2 | 0 | 0 | 2 |
| urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
| Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 3 | 3 | 6 |
| Alpha-2C adrenergic receptor | 0 | 3 | 3 | 6 |
| Alpha-2A adrenergic receptor | 0 | 3 | 3 | 6 |
| Alpha-1A adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-1B adrenergic receptor | 0 | 2 | 1 | 3 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Nischarin | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| Taste receptor type 2 member 31 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 60 | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
| Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
| Taste receptor type 2 member 14 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 13 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 9 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 4 | 0 | 0 | 1 | 1 |
| Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
| Monocarboxylate transporter 4 | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 2 | 0 | 0 | 0 | 1 |
| Monocarboxylate transporter 1 | 0 | 0 | 0 | 1 |
| C-terminal-binding protein 2 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 2 | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
| Sphingosine kinase 2 | 0 | 2 | 0 | 2 |
| Sphingosine kinase 1 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| PINK1 | 1 | 0 | 0 | 1 |
| Parkin | 1 | 0 | 0 | 1 |
| photoreceptor-specific nuclear receptor | 0 | 1 | 0 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
| Insulin receptor | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
| Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 2 | 0 | 2 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 0 | 1 | 1 |
| Renin | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 2 | 2 | 5 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Adenosine receptor A2b | 0 | 1 | 0 | 2 |
| Adenosine receptor A1 | 0 | 2 | 1 | 5 |
| Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
| Chitotriosidase-1 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 0 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 0 | 1 | 1 |
| Endochitinase B1 | 0 | 1 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Trace amine-associated receptor 1 | 0 | 1 | 0 | 1 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Protease | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |